Hi-Tech Pharmacal deals with Warner Chilcott to market generic Dovonex

AMITYVILLE, N.Y. Hi-Tech Pharmacal announced recently that it has entered into a distribution and supply agreement with a subsidiary of Warner Chilcott to market the authorized generic version of Warner Chilcott’s Dovonex scalp solution.

Calcipotriene solution 0.005 percent is indicated for the topical treatment of psoriasis of the scalp.

According to IMS, Dovonex scalp solution had sales of approximately $18 million in 2007.

Hi-Tech will pay Warner Chilcott a portion of the profits from the sale of the authorized generic product. Hi-Tech will begin shipping generic calcipotriene scalp solution under its label immediately.